The IL6(-174G/C) polymorphism is a prognostic factor for survival after treatment initiation in Waldenstrom macroglobulinemia patients aged 65 years or less.
Stéphanie
S
Poulain
Isabelle
I
Dervite
Xavier
X
Leleu
Valérie
V
Coiteux
Patrick
P
Duthilleul
Pierre
P
Morel
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D015850:Interleukin-6 / Q000235:genetics* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D011110:Polymorphism, Genetic; D011379:Prognosis; D016896:Treatment Outcome; D008258:Waldenstrom Macroglobulinemia / Q000235:genetics* / Q000401:mortality
D015850:Interleukin-6